The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease

NCT01165567 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: sarpogrelate

Sponsor

Seoul National University Boramae Hospital